ATHA – athira pharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ATHA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/6

04:05 pm

atha

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update

Medium Report

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update

Report

10/24

12:16 pm

atha

Athira Pharma (NASDAQ:ATHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Athira Pharma (NASDAQ:ATHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Report

9/19

10:03 am

atha

Athira Pharma (NASDAQ:ATHA) was given a new $4.00 price target on by analysts at Mizuho.

Low Report

Athira Pharma (NASDAQ:ATHA) was given a new $4.00 price target on by analysts at Mizuho.

Report

9/11

09:31 am

atha

Athira Pharma Announces Reverse Stock Split [Yahoo! Finance]

Low Report

Athira Pharma Announces Reverse Stock Split [Yahoo! Finance]

Report

9/11

09:00 am

atha

Athira Pharma Announces Reverse Stock Split

Medium Report

Athira Pharma Announces Reverse Stock Split

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.